Antisense Therapeutics (ASX: ANP) – Webinar Presentation

Mark Diamond – Managing Director and CEO –  Antisense Therapeutics is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases.